Close Menu

The success of companies such as 23andMe and Navigenics hinges on good data security, says Blaine Bettinger at the Genetic Genealogist. "A single security breach could potentially drive away future customers," he blogs. Bettinger also points to Ryan Calo's discussion of a panel at Stanford.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.